Gerät zur Kontinuierlichen Glukoseüberwachung (cgm)

Details

Veröffentlichungs-Nr.

EP4759223

Anmeldetag

16. Dezember 2024

Veröffentlichung

17. Juni 2026

Rechtsraum

EP

IPC

A61B5/00, A61B5/145

Abstract

This invention relates to medical devices, particularly a continuous glucose monitoring (CGM) device designed for the diagnosis and monitoring of metabolic diseases such as diabetes. The invention offers an innovative monitoring solution for both type 1 diabetes, which arises from insufficient insulin production, and the more common type 2 diabetes, which is associated with insulin resistance. By enabling continuous blood sugar monitoring, the invention provides a user-friendly, eco-friendly, and cost-effective solution for diabetes management. The device allows real-time monitoring of glucose levels and delivers visual, auditory, and vibrational alerts to the user. As a result, it establishes a safer, more practical, and continuous health management system for users.

Anmelder

Firma

Primewise Teknoloji A.S.

Land

🇹🇷 Türkei

Fachgebiete